A Case of Peritoneal Tuberculosis with Poncet's Disease in a Patient Treated with Infliximab
Journal of Rheumatic Diseases
; : 55-59, 2011.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-104645
Biblioteca responsável:
WPRO
ABSTRACT
Infliximab is a chimeric mouse/human monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha) that is used worldwide to treat rheumatic disease. However, the reactivation of tuberculosis, including extrapulmonary menifestation, is a severe side effect of anti-TNF-alpha treatment. Mycobacterium tubercluosis causes two forms of joint involvement, TB arthritis and Poncet's disease. Poncet's disease is a rare aseptic form of arthritis, known as reactive arthritis in tuberculosis. We encountered a case of tuberculous peritonitis with Poncet's disease in a 38-yearold man with a history of ankylosing spondylitis that was treated with infliximab. We report this case with a review of the literature.
Texto completo:
Disponível
Contexto em Saúde:
Doenças Negligenciadas
Problema de saúde:
Doenças Negligenciadas
/
Tuberculose
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Artrite
/
Espondilite Anquilosante
/
Tuberculose
/
Peritonite Tuberculosa
/
Doenças Reumáticas
/
Fator de Necrose Tumoral alfa
/
Artrite Reativa
/
Infliximab
/
Articulações
/
Anticorpos Monoclonais
Limite:
Humanos
Idioma:
Coreano
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2011
Tipo de documento:
Artigo